Origen Therapeutics
closedOrigen Therapeutics develops therapeutic products from avian transgenic animal technology.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD20—30m (Dealroom.co estimates Aug 2010.)
Burlingame California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$2.0m | Grant | ||
N/A | $3.7m | Early VC | |
Total Funding | CAD7.8m |